PT_Plastics Today

Plastics Today, September 2015

Issue link:

Contents of this Issue


Page 26 of 67

Medical Technology PlasTicsToday.coM global PlasTics RePoRT 2015 27 150 million [insulin] pens annually in our Finland facility. That requires a substantial team with a focus on uptime, expected yields, and so forth. Expertise in tooling and automation at all lev- els—design, development, validation and sustaining efforts—is a necessity." Consistent investment in technol- ogy that benefits medical device OEMs through an increase in quality and a reduction in cost has been a recipe for success at Plastic Molding Manufac- turing (Hudson, MA), which recently added cleanroom two-shot molding to its portfolio to keep up with changing demands and technologies. This invest- ment was prompted by a longtime cus- tomer who was having difficulty bonding polycarbonate/thermoplastic elastomer on a device. The solution ultimately "required the purchase of a 110-ton, two-shot molding machine from Arburg, and we are now going through the qualification and validation process," says Vice President Ron Bodeau. Demand for multi-shot molding is growing from medical customers, he adds. "Multi-shot molding offers alterna- tives and flexibility," explains Bodeau. "Customers want us to consolidate the production process into a single step, where possible, so that they can buy one SKU instead of two. They want a finished product that can go straight into packaging or sterilization." Bodeau cites a number of other benefits includ- Scientific molding requires strong processes and methodologies, which mesh well with the demands of medical device OEMs, says GW Plastics.

Articles in this issue

Links on this page

Archives of this issue

view archives of PT_Plastics Today - Plastics Today, September 2015